STE (Steris) Long-Term Capital Lease Obligation : $125 Mil (As of Mar. 2025)

View and export this data going back to 1992. Start your Free Trial

What is Steris Long-Term Capital Lease Obligation?

Steris's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2025 was $125 Mil.

Steris's quarterly Long-Term Capital Lease Obligation declined from Sep. 2024 ($133 Mil) to Dec. 2024 ($124 Mil) but then increased from Dec. 2024 ($124 Mil) to Mar. 2025 ($125 Mil).

Steris's annual Long-Term Capital Lease Obligation increased from Mar. 2023 ($140 Mil) to Mar. 2024 ($146 Mil) but then declined from Mar. 2024 ($146 Mil) to Mar. 2025 ($125 Mil).

Steris Long-Term Capital Lease Obligation Historical Data

The historical data trend for Steris's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Steris Long-Term Capital Lease Obligation Chart

Steris Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

129.67

155.06

139.56

145.83

124.64

Steris Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															145.83	139.36	133.15	123.72	124.64

Steris (NYSE:STE) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Steris Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Steris's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Steris Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Steris PLC (NYSE:STE) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

S1TE34:Brazil

Address

5960 Heisley Road, Mentor, OH, USA, 44060

Website

https://www.steris.com

Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.

Executives

Cary L Majors	officer: VP, N America Com Operations	5960 HEISLEY ROAD, MENTOR OH 44060
Michael J Tokich	director, officer: Sr. Vice Pres., CFO	C/O STERIS CORP, 5960 HEISLEY RD, MENTOR OH 44060
Christopher S Holland	director	ARAMARK CORP, 1101 MARKET ST 29TH FLOOR, PHILADELPHIA PA 19107
Julia Madsen	officer: Senior VP, Life Sciences	5960 HEISLEY ROAD, MENTOR OH 44060
Renato Tamaro	officer: V.P. & Corporate Treasurer	5960 HEISLEY ROAD, MENTOR OH 44060
Cynthia L Feldmann	director	17 WINTHROP ROAD, WAYLAND MA 01778
Mohsen Sohi	director	C/O STERIS CORPORATION, 5960 HEISLEY ROAD, MENTOR OH 44060
Karen L Burton	officer: VP, Controller & CAO	5960 HEISLEY ROAD, MENTOR OH 44060
Jacqueline B Kosecoff	director	5960 HEISLEY ROAD, MENTOR OH 44060
Richard C Breeden	director	100 SOUTH WACKER, SUITE 1800, CHICAGO IL 60606
Esther M. Alegria	director	2642 MICHELLE DRIVE, SUITE 200, TUSTIN CA 92780
John Adam Zangerle	director, officer: Sr. VP, Gen Counsel, and Sec.	5960 HEISLEY ROAD, MENTOR OH 44060
Andrew Xilas	officer: SVP and GM, Dental	5960 HEISLEY ROAD, MENTOR OH 44060
Paul Edward Martin	director	C/O UNISYS CORPORATION, 801 LAKEVIEW DRIVE, SUITE 100, BLUE BELL PA 19422
David B Lewis	director